MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, BBNX made $27,253,000 in revenue. -$14,004,000 in net income. Net profit margin of -51.39%.

Income Overview

Revenue
$27,253,000
Net Income
-$14,004,000
Net Profit Margin
-51.39%
EPS
-$0.33
Unit: Dollar
Revenue Breakdown
    • ILet
    • Single Use Products
    • Single Use Products
    • ILet

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Net sales
27,253,000 23,238,000 17,639,000 16,281,000
Cost of sales
12,134,000 10,735,000 8,668,000 7,309,000
Gross profit
15,119,000 12,503,000 8,971,000 8,972,000
Research and development
8,195,000 8,873,000 7,590,000 6,546,000
Sales and marketing
16,045,000 15,623,000 13,402,000 9,271,500
General and administrative
7,922,000 7,879,000 6,621,000 4,467,250
Total operating expenses
32,162,000 32,375,000 27,613,000 20,284,750
Loss from operations
-17,043,000 -19,872,000 -18,642,000 -11,312,750
Interest income
2,833,000 3,005,000 2,436,000 977,250
Other income (expense), net
1,000 -2,000 --500
Change in fair value of warrant liabilities
0 0 12,450,000 3,353,000
Total other income (expense), net
2,834,000 3,003,000 -10,014,000 -2,376,250
Net loss
-14,209,000 -16,869,000 -28,656,000 -13,689,000
Unrealized gain (loss) on short-term investments
205,000 -91,000 175,000 -18,000
Comprehensive loss
-14,004,000 -16,960,000 -28,481,000 -13,707,000
Earnings per share, basic
-0.33 -0.39 -0.93 -2.15
Earnings per share, diluted
-0.33 -0.39 -0.93 -2.15
Weighted average number of shares outstanding, basic
43,634,006 43,390,652 30,714,769 1,591,266
Weighted average number of shares outstanding, diluted
43,634,006 43,390,652 30,714,769 1,591,266
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Single Use Products$6,090,000 ILet$148,000 Single Use Products$6,840,000 ILet$14,175,000 Comprehensive loss-$14,004,000 Unrealized gain (loss) onshort-term investments$205,000 Other income(expense), net$1,000 Interest income$2,833,000 Pharmacy Benefit PlanChannel$6,238,000 Durable MedicalEquipment Channel$21,015,000 Net loss-$14,209,000 Total other income(expense), net$2,834,000 Net sales$27,253,000 Loss from operations-$17,043,000 Gross profit$15,119,000 Cost of sales$12,134,000 Total operatingexpenses$32,162,000 General andadministrative$7,922,000 Sales and marketing$16,045,000 Research and development$8,195,000

Beta Bionics, Inc. (BBNX)

Beta Bionics, Inc. (BBNX)